title: Rituximab for pure red cell aplasia after ABO-mismatched allogeneic peripheral blood progenitor cell transplantation.
authors.forename: Federica
authors.initials: F
authors.lastname: Sorà
authors.forename: Silvia
authors.initials: S
authors.lastname: De Matteis
authors.forename: Nicola
authors.initials: N
authors.lastname: Piccirillo
authors.forename: Patrizia
authors.initials: P
authors.lastname: Chiusolo
authors.forename: Luca
authors.initials: L
authors.lastname: Laurenti
authors.forename: Rossana
authors.initials: R
authors.lastname: Putzulu
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Leone
authors.forename: Simona
authors.initials: S
authors.lastname: Sica
mesh_terms: D000017:ABO Blood-Group System; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D012010:Red-Cell Aplasia, Pure / Q000188:drug therapy* / Q000209:etiology; D000069283:Rituximab
chemical_list: D000017:ABO Blood-Group System; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab